Perhimpunan Dokter Hipertensi Indoensia. Konsensus Penatalaksanaan Hipertensi 2019. Lukito AA, Harmeiwaty E, Hustrini NM, editors. Jakarta: Perhimpunan Dokter Hipertensi Indoensia; 2019.

Committee ADAPP. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022. Diabetes Care 2021;45(Supplement_1):S17–38. https://doi.org/10.2337/dc22-S002

International Diabetes Federation. The IDF consensus worldwide definition of the Metabolic Syndrome. Brussels: International Diabetes Federation; 2006.

Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. New England Journal of Medicine 2021;385(19):1737–49. http://www.nejm.org/doi/10.1056/NEJMoa2102953

D'Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General Cardiovascular Risk Profile for Use in Primary Care. Circulation 2008;117(6):743–53. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.107.699579

Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, Stevens G, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Glob Health 2019;7(10):e1332–45. https://doi.org/10.1016/S2214-109X(19)30318-3

American Diabetes Association Professional Practice Committee; 3. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2025. Diabetes Care 2025;48(Supplement_1):S50–S58. https://doi.org/10.2337/dc25-S003

Khan SS, Matsushita K, Sang Y, et al. Development and Validation of the American Heart Association's PREVENT Equations. Circulation 2024;149(6):430-449. doi:10.1161/CIRCULATIONAHA.123.067626

Muntner P, Colantonio LD, Cushman M, et al. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA 2014;311(14):1406-1415. doi:10.1001/jama.2014.2630